Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.45 |
| ▸ | P2RY10 | O00398 | 8/20 | 0.38 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.38 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.36 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9951445 | 1.00 | PLA2G2C (0.45) | PLA2G2CP2RY10GPR34PLA2G2DGPR174 | |
| SCHEMBL4737508 | 1.00 | PLA2G2C (0.45) | PLA2G2CP2RY10GPR34PLA2G2DGPR174 | |
| SCHEMBL8628861 | 0.94 | P2RY10 (0.43) | P2RY10GPR34 | |
| SCHEMBL8627715 | 0.91 | S1PR1 (0.46) | P2RY10GPR34 | |
| SCHEMBL9166758 | 0.86 | PLA2G2C (0.43) | PLA2G2CP2RY10GPR34 | |
| SCHEMBL6372215 | 0.86 | PLA2G2C (0.46) | PLA2G2CP2RY10GPR34PLA2G2DGPR174 | |
| SCHEMBL15022342 | 0.86 | PLA2G2C (0.46) | PLA2G2CP2RY10GPR34PLA2G2DGPR174 | |
| SCHEMBL16964730 | 0.84 | P2RY10 (0.43) | PLA2G2CP2RY10GPR34 | |
| SCHEMBL17595343 | 0.83 | S1PR1 (0.49) | P2RY10GPR34 | |
| SCHEMBL9951988 | 0.83 | S1PR1 (0.49) | P2RY10GPR34 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458474-A1 | COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF | Modernatx, Inc. (US) | 2019-03-27 | — | — | EP | disclosed |
| WO-2017201325-A1 | COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF | MODERNATX, INC. (US) | 2017-11-23 | — | — | WO | disclosed |
| EP-2654779-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | Ludwig Institute for Cancer Research, Ltd. (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012088414-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2012-06-28 | — | — | WO | disclosed |